Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
BI 3032950 is a TREM-1 antagonist currently in Phase 2 development for immunology applications, specifically being investigated for moderate to severe UC in trial (NCT06636656)
Madrigal Pharmaceutical, West Conshohocken, PA, USA), which was recently approved for use in the United States (US) by the US Food and Drug Administration [26-29]
How Can You Minimize Discomfort
Patient confidence and physician comfort are critical for longcycle injectable therapies
Please note that a credit o To schedule your first appointment, visit our Book Now page and select your state
US$ 21.54
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 27.73
US$ 20.17
US$ 23.16
US$ 20.80
US$ 24.01
